• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者肺栓塞的患病率及危险因素:一项系统评价和荟萃分析

The prevalence and risk factors of pulmonary embolism in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

作者信息

Li Mingzhu, Jiang Yeqian, Xu Ying, Li Qianbing

机构信息

Department of Respiratory and Critical Care Medicine, Anqing First People's Hospital of Anhui Medical University, 42 Xiaosu Road, Yingjiang District, Anqing, 246003, China.

The Fifth Clinical College of Anhui Medical University, Hefei, China.

出版信息

Thromb J. 2025 Apr 29;23(1):42. doi: 10.1186/s12959-025-00728-6.

DOI:10.1186/s12959-025-00728-6
PMID:40301960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12039155/
Abstract

BACKGROUND

An increased prevalence of PE has been found in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD). Early identification of risk factors for the development of PE in patients with AECOPD and intervention is important. Therefore, we comprehensively pool and analyze the prevalence and risk factors of PE among patients experiencing AECOPD, aiming to provide valuable insights for clinical-based diagnostic determination and prevention of PE in the AECOPD patient population.

METHODS

A systematic literature search was conducted for studies reporting the incidence and risk factors for PE in patients with AECOPD. Study quality was assessed using the modified Newcastle-Ottawa Quality Assessment Scale. The degree of heterogeneity was assessed by the I statistic. The publication bias (studies ≥ 10) was evaluated using Egger's test.

RESULTS

Among the 1421 studies initially retrieved, 22 articles were ultimately selected and incorporated into the analysis. Based on the meta-analysis and the review's updated findings, the prevalence of PE in AECOPD is 17.82% (95% CI 12.72%-23.57%, P<0.001). The following factors were identified as risk factors for PE among patients with AECOPD: age(weighted mean difference [WMD] 2.0119, 95% CI 0.7126-3.3133, I = 51.8%, P = 0.02), males(odds ratio [OR] 0.9528, 95% CI 0.6869-1.3216, I = 65.0%, P<0.001), obesity(OR 1.3086, 95% CI 0.1895-9.0385, I = 74.5%, P = 0.02), malignant disease(OR 1.5902, 95%CI 0.9689-2.6097, I = 54.7%, P = 0.03), hypertension(OR 1.0663, 95%CI 0.7920-1.4355, I = 57.7%, P = 0.009), immobilization ≥ 3d(OR 3.9158, 95% CI 1.0925-14.0354, I = 91.6%, P<0.001), edema of lower limb(OR 2.1558, 95% CI 1.3365-3.4773, I = 75.4%, P<0.001), pulmonary hypertension(OR 1.3146, 95%CI 0.7481-2.3100, I = 70.1%, P = 0.04), cough(OR 0.7084, 95%CI 0.1304-3.8497, I = 88.8%, P<0.001), purulent sputum(OR 0.7570, 95%CI 0.4005-1.4309, I = 61.9%, P = 0.049), and D-dimer(WMD 0.8619, 95%CI 0.0449-1.6789, I = 91.4%, P<0.001), C-reactive protein(CRP)(WMD 0.8852, 95%CI -4.0639-5.8344, I = 76.4%, P = 0.005) or fibrinogen(WMD 0.8663, 95%CI -0.2572-1.9898, I = 92.2%, P<0.001) levels. Clinical risk factors(including S1Q3 pattern on electrocardiograph(ECG), hospital stay and home oxygen therapy) showed no significant association with the occurrence of PE (P>0.05).

CONCLUSIONS

This updated meta-analysis and systematic review revealed that the prevalence of pulmonary embolism in the AECOPD was 17.82%. This figure may vary depending on how the diagnostic procedure is carried out. Age, males, obesity, malignant disease, hypertension, immobilization ≥ 3d, edema of lower limb, pulmonary hypertension, cough, purulent sputum, and D-dimer, CRP or fibrinogen level may serve as potential risk factors for PE among patients with AECOPD.

摘要

背景

慢性阻塞性肺疾病急性加重期(AECOPD)患者中肺栓塞(PE)的患病率有所增加。早期识别AECOPD患者发生PE的危险因素并进行干预很重要。因此,我们全面汇总并分析了AECOPD患者中PE的患病率及危险因素,旨在为基于临床的AECOPD患者群体PE诊断判定和预防提供有价值的见解。

方法

对报告AECOPD患者PE发病率和危险因素的研究进行系统文献检索。使用改良的纽卡斯尔-渥太华质量评估量表评估研究质量。用I统计量评估异质性程度。使用Egger检验评估发表偏倚(研究≥10项)。

结果

在最初检索的1421项研究中,最终选择了22篇文章纳入分析。基于荟萃分析和综述的最新结果,AECOPD患者中PE的患病率为17.82%(95%可信区间12.72%-23.57%,P<0.001)。以下因素被确定为AECOPD患者发生PE的危险因素:年龄(加权均数差[WMD]2.0119,95%可信区间0.7126-3.3133,I=51.8%,P=0.02)、男性(比值比[OR]0.9528,95%可信区间0.6869-1.3216,I=65.0%,P<0.001)、肥胖(OR 1.3086,95%可信区间0.1895-9.0385,I=74.5%,P=0.02)、恶性疾病(OR 1.5902,95%可信区间0.9689-2.6097,I=54.7%,P=0.03)、高血压(OR 1.0663,95%可信区间0.7920-1.4355,I=57.7%,P=0.009)、制动≥3天(OR 3.9158,95%可信区间1.0925-14.0354,I=91.6%,P<0.001)、下肢水肿(OR 2.1558,95%可信区间1.3365-3.4773,I=75.4%,P<0.001)、肺动脉高压(OR 1.3146,95%可信区间0.7481-2.3100,I=70.1%,P=0.04)、咳嗽(OR 0.7084,95%可信区间0.1304-3.8497,I=88.8%,P<0.001)、脓性痰(OR 0.7570,95%可信区间0.4005-1.4309,I=61.9%,P=0.049)以及D-二聚体(WMD 0.8619,95%可信区间0.0449-1.6789,I=91.4%,P<0.001)、C反应蛋白(CRP)(WMD 0.8852,95%可信区间-4.0639-5.8344,I=76.4%,P=0.005)或纤维蛋白原(WMD 0.8663,95%可信区间-0.2572-1.9898,I=92.2%,P<0.001)水平。临床危险因素(包括心电图[ECG]上的S1Q3型、住院时间和家庭氧疗)与PE的发生无显著关联(P>0.05)。

结论

这项更新的荟萃分析和系统评价显示,AECOPD患者中肺栓塞的患病率为17.82%。该数字可能因诊断程序的实施方式而异。年龄、男性、肥胖、恶性疾病、高血压、制动≥3天、下肢水肿、肺动脉高压、咳嗽、脓性痰以及D-二聚体、CRP或纤维蛋白原水平可能是AECOPD患者发生PE的潜在危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/bdadaa72cb2a/12959_2025_728_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/805143c9a5f3/12959_2025_728_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/9fed253d2ae3/12959_2025_728_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/aff91c5692f3/12959_2025_728_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/c38414362025/12959_2025_728_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/31f3d4bd5970/12959_2025_728_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/bdadaa72cb2a/12959_2025_728_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/805143c9a5f3/12959_2025_728_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/9fed253d2ae3/12959_2025_728_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/aff91c5692f3/12959_2025_728_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/c38414362025/12959_2025_728_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/31f3d4bd5970/12959_2025_728_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db76/12039155/bdadaa72cb2a/12959_2025_728_Fig6_HTML.jpg

相似文献

1
The prevalence and risk factors of pulmonary embolism in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.慢性阻塞性肺疾病患者肺栓塞的患病率及危险因素:一项系统评价和荟萃分析
Thromb J. 2025 Apr 29;23(1):42. doi: 10.1186/s12959-025-00728-6.
2
Chronic obstructive pulmonary disease exacerbation purulence status and its association with pulmonary embolism: protocol for a systematic review with meta-analysis.慢性阻塞性肺疾病加重期脓性状态及其与肺栓塞的相关性:系统评价与荟萃分析的方案。
BMJ Open. 2024 Jun 19;14(6):e085328. doi: 10.1136/bmjopen-2024-085328.
3
Prevalence of Pulmonary Embolism and Deep Venous Thromboembolism in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.慢性阻塞性肺疾病急性加重患者中肺栓塞和深静脉血栓栓塞的患病率:一项系统评价和荟萃分析
Front Cardiovasc Med. 2022 Mar 9;9:732855. doi: 10.3389/fcvm.2022.732855. eCollection 2022.
4
[Risk factors for pulmonary embolism in acute exacerbation of chronic obstructive pulmonary disease].[慢性阻塞性肺疾病急性加重期肺栓塞的危险因素]
Zhonghua Jie He He Hu Xi Za Zhi. 2016 Apr 12;39(4):298-303. doi: 10.3760/cma.j.issn.1001-0939.2016.04.010.
5
Prevalence of pulmonary embolism in patients with acute exacerbations of COPD: A systematic review and meta-analysis.慢性阻塞性肺疾病急性加重期患者肺栓塞的患病率:系统评价和荟萃分析。
Am J Emerg Med. 2021 Dec;50:606-617. doi: 10.1016/j.ajem.2021.09.041. Epub 2021 Sep 21.
6
Prevalence, Risk Factor and Clinical Characteristics of Venous Thrombus Embolism in Patients with Acute Exacerbation of COPD: A Prospective Multicenter Study.COPD 急性加重期患者静脉血栓栓塞症的患病率、危险因素及临床特征:一项前瞻性多中心研究。
Int J Chron Obstruct Pulmon Dis. 2023 May 18;18:907-917. doi: 10.2147/COPD.S410954. eCollection 2023.
7
The challenges of identifying pulmonary embolism in patients hospitalized for exacerbations of COPD.在因慢性阻塞性肺疾病(COPD)急性加重而住院的患者中识别肺栓塞的挑战。
Respir Med Res. 2024 Nov;86:101122. doi: 10.1016/j.resmer.2024.101122. Epub 2024 Jun 22.
8
[Correlation between serum interleukin-38 and acute exacerbation of chronic obstructive pulmonary disease with pulmonary embolism].[血清白细胞介素-38与慢性阻塞性肺疾病合并肺栓塞急性加重的相关性]
Zhonghua Yi Xue Za Zhi. 2019 Mar 26;99(12):929-933. doi: 10.3760/cma.j.issn.0376-2491.2019.12.010.
9
Prevalence and risk factors of pulmonary embolism in acute exacerbation of chronic obstructive pulmonary disease and its impact on outcomes: a systematic review and meta-analysis.慢性阻塞性肺疾病急性加重期合并肺栓塞的患病率、相关危险因素及其对结局的影响:系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2604-2616. doi: 10.26355/eurrev_202103_25424.
10
Prevalence and predictors of pulmonary embolism in patients with acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重患者肺栓塞的患病率及预测因素
Lung India. 2021 Nov-Dec;38(6):533-539. doi: 10.4103/lungindia.lungindia_79_21.

引用本文的文献

1
The predictive value of 3 risk assessment models for pulmonary embolism in acute exacerbation of chronic obstructive pulmonary disease.3种风险评估模型对慢性阻塞性肺疾病急性加重期肺栓塞的预测价值。
Medicine (Baltimore). 2025 Aug 8;104(32):e43547. doi: 10.1097/MD.0000000000043547.

本文引用的文献

1
Prevalence, risk factors, and clinical characteristics of pulmonary embolism in patients with acute exacerbation of COPD in Plateau regions: a prospective cohort study.高原地区慢性阻塞性肺疾病急性加重期患者肺栓塞的患病率、危险因素及临床特征:一项前瞻性队列研究。
BMC Pulm Med. 2024 Feb 27;24(1):102. doi: 10.1186/s12890-024-02915-z.
2
Prevalence, Risk Factor and Clinical Characteristics of Venous Thrombus Embolism in Patients with Acute Exacerbation of COPD: A Prospective Multicenter Study.COPD 急性加重期患者静脉血栓栓塞症的患病率、危险因素及临床特征:一项前瞻性多中心研究。
Int J Chron Obstruct Pulmon Dis. 2023 May 18;18:907-917. doi: 10.2147/COPD.S410954. eCollection 2023.
3
Sputum Color as a Marker for Bacteria in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis.
痰液颜色作为慢性阻塞性肺疾病急性加重期细菌感染的标志物:一项系统评价与荟萃分析
Ann Am Thorac Soc. 2023 May;20(5):738-748. doi: 10.1513/AnnalsATS.202204-319OC.
4
Acute Pulmonary Embolism: A Review.急性肺栓塞:综述。
JAMA. 2022 Oct 4;328(13):1336-1345. doi: 10.1001/jama.2022.16815.
5
The Role of Smoking in Asthma and Chronic Obstructive Pulmonary Disease Overlap.吸烟在哮喘和慢性阻塞性肺疾病重叠中的作用。
Immunol Allergy Clin North Am. 2022 Aug;42(3):615-630. doi: 10.1016/j.iac.2022.03.004. Epub 2022 Jun 30.
6
Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis.全球、区域和国家 2019 年慢性阻塞性肺疾病(COPD)的患病率、危险因素:系统评价和建模分析。
Lancet Respir Med. 2022 May;10(5):447-458. doi: 10.1016/S2213-2600(21)00511-7. Epub 2022 Mar 10.
7
Acute Pulmonary Embolism: Prognostic Role of Computed Tomography Pulmonary Angiography (CTPA).急性肺栓塞:计算机断层扫描肺动脉造影(CTPA)的预后作用
Tomography. 2022 Feb 14;8(1):529-539. doi: 10.3390/tomography8010042.
8
Risk factors of pulmonary embolism in the elderly patients: a retrospective study.老年患者肺栓塞的危险因素:一项回顾性研究。
Aging Clin Exp Res. 2022 May;34(5):1133-1137. doi: 10.1007/s40520-021-02031-6. Epub 2022 Jan 10.
9
Age-Adjusted D-Dimer in the Prediction of Pulmonary Embolism: Systematic Review and Meta-analysis.年龄调整 D-二聚体在肺栓塞预测中的应用:系统评价和荟萃分析。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211054996. doi: 10.1177/21501327211054996.
10
Prevalence and predictors of pulmonary embolism in patients with acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重患者肺栓塞的患病率及预测因素
Lung India. 2021 Nov-Dec;38(6):533-539. doi: 10.4103/lungindia.lungindia_79_21.